Survivin expression has been confirmed in some solid tumors, including gastric, colorectal, pancreatic and hepatocellular cancers, sarcoma, and hematologic neoplasias, while the expression of EPR-1 has been detected in a relatively limited number of tumors; the simultaneous expression of EPR-1 and Survivin has been demonstrated by very few studies [9], [20]. The gene discussed is BIRC5; the disease is hepatocellular carcinoma.